OIA
MDT icon

Oakmont Investment Advisors’s Medtronic MDT Stock Holding History

Oakmont Investment Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Buy
26,858
+508
+2% +$41K 1.46% 18
2026
Q1 		$2.28M Sell
26,350
-1,556
-6% -$149K 2.09% 11
2025
Q4 		$2.68M Buy
+27,906
New +$2.71M 1.96% 9

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Oakmont Investment Advisors's MDT Position: Q2 2026 in Review

Oakmont Investment Advisors increased its Medtronic (MDT) stake by 1.9% in Q2 2026, buying an estimated $41K and bringing the position to 26,858 shares worth $2.1M. The position accounts for 1.46% of the portfolio, ranked #18.

Oakmont Investment Advisors first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.68M in Q4 2025. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Oakmont Investment Advisors held 26,858 shares of Medtronic worth $2.1M as of Q2 2026.
  • Oakmont Investment Advisors bought 508 Medtronic shares in Q2 2026, an estimated $41K.
  • Medtronic made up 1.46% of Oakmont Investment Advisors's portfolio in Q2 2026, its #18 holding.
  • Oakmont Investment Advisors first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Oakmont Investment Advisors's Medtronic position peaked at $2.68M in Q4 2025.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Oakmont Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.